190 related articles for article (PubMed ID: 16413806)
1. Effects of atorvastatin on lipid metabolism in normolipidemic and hereditary hyperlipidemic, non-laying hens.
Elkin RG; Zhong Y; Donkin SS; Hengstschläger-Ottnad E; Schneider WJ
Comp Biochem Physiol B Biochem Mol Biol; 2006 Mar; 143(3):319-29. PubMed ID: 16413806
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin increases expression of low-density lipoprotein receptor mRNA in human circulating mononuclear cells.
Pocathikorn A; Taylor RR; Mamotte CD
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):471-6. PubMed ID: 19930424
[TBL] [Abstract][Full Text] [Related]
3. Mechanism study of chitosan on lipid metabolism in hyperlipidemic rats.
Xu G; Huang X; Qiu L; Wu J; Hu Y
Asia Pac J Clin Nutr; 2007; 16 Suppl 1():313-7. PubMed ID: 17392126
[TBL] [Abstract][Full Text] [Related]
4. Pituitary progesterone receptor expression and plasma gonadotrophin concentrations in the reproductively dysfunctional mutant restricted ovulator chicken.
Ocón-Grove OM; Maddineni S; Hendricks GL; Elkin RG; Proudman JA; Ramachandran R
Domest Anim Endocrinol; 2007 Apr; 32(3):201-15. PubMed ID: 16677794
[TBL] [Abstract][Full Text] [Related]
5. Select 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors vary in their ability to reduce egg yolk cholesterol levels in laying hens through alteration of hepatic cholesterol biosynthesis and plasma VLDL composition.
Elkin RG; Yan Z; Zhong Y; Donkin SS; Buhman KK; Story JA; Turek JJ; Porter RE; Anderson M; Homan R; Newton RS
J Nutr; 1999 May; 129(5):1010-9. PubMed ID: 10222393
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
[TBL] [Abstract][Full Text] [Related]
7. (TTA)n polymorphism in 3-hydroxy-3-methylglutaryl-coenzyme A and response to atorvastatin in coronary artery disease patients.
Noriega V; Pennanen C; Sánchez MP; Chiong M; Llancaqueo M; Lavandero S; Prieto JC
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):211-5. PubMed ID: 19067673
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific effects of atorvastatin on 3-hydroxy-3-methylglutarylcoenzyme A reductase expression and activity in spontaneously hypertensive rats.
Chen GP; Yao L; Lu X; Li L; Hu SJ
Acta Pharmacol Sin; 2008 Oct; 29(10):1181-6. PubMed ID: 18817622
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol-lowering effect of NK-104, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, in guinea pig model of hyperlipidemia.
Aoki T; Yamazaki H; Suzuki H; Tamaki T; Sato F; Kitahara M; Saito Y
Arzneimittelforschung; 2001; 51(3):197-203. PubMed ID: 11304935
[TBL] [Abstract][Full Text] [Related]
10. High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production.
Roglans N; Verd JC; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
Lipids; 2002 May; 37(5):445-54. PubMed ID: 12056585
[TBL] [Abstract][Full Text] [Related]
11. Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens.
Martín-Castillo A; Castells MT; Adánez G; Polo MT; Pérez BG; Ayala I
Biomed Pharmacother; 2010 Apr; 64(4):275-81. PubMed ID: 19932590
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.
Hogue JC; Lamarche B; Deshaies Y; Tremblay AJ; Bergeron J; Gagné C; Couture P
Metabolism; 2008 Feb; 57(2):246-54. PubMed ID: 18191056
[TBL] [Abstract][Full Text] [Related]
13. The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance.
Pallebage-Gamarallage MM; Galloway S; Johnsen R; Jian L; Dhaliwal S; Mamo JC
Br J Nutr; 2009 Feb; 101(3):340-7. PubMed ID: 18631412
[TBL] [Abstract][Full Text] [Related]
14. Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties.
Uyuklu M; Meiselman HJ; Baskurt OK
Clin Hemorheol Microcirc; 2007; 36(1):25-33. PubMed ID: 17211059
[TBL] [Abstract][Full Text] [Related]
15. Modulation by geraniol of gene expression involved in lipid metabolism leading to a reduction of serum-cholesterol and triglyceride levels.
Galle M; Kladniew BR; Castro MA; Villegas SM; Lacunza E; Polo M; de Bravo MG; Crespo R
Phytomedicine; 2015 Jul; 22(7-8):696-704. PubMed ID: 26141755
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical modifications induced by statins therapy on human erythrocytes membranes.
Broncel M; Bała A; Koter-Michalak M; Duchnowicz P; Wojsznis W; Chojnowska-Jezierska J
Wiad Lek; 2007; 60(7-8):321-8. PubMed ID: 18175550
[TBL] [Abstract][Full Text] [Related]
17. Effects of high-dose statin on the human hepatic expression of genes involved in carbohydrate and triglyceride metabolism.
Pramfalk C; Parini P; Gustafsson U; Sahlin S; Eriksson M
J Intern Med; 2011 Mar; 269(3):333-9. PubMed ID: 21083855
[TBL] [Abstract][Full Text] [Related]
18. Dietary coenzyme Q10 suppressed hepatic hydroxymethylglutaryl-CoA reductase activity in laying hens.
Honda K; Saneyasu T; Motoki T; Park Y; Kamisoyama H
Biosci Biotechnol Biochem; 2013; 77(7):1572-4. PubMed ID: 23832331
[TBL] [Abstract][Full Text] [Related]
19. Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats.
Ji G; Zhao X; Leng L; Liu P; Jiang Z
Lipids Health Dis; 2011 Jan; 10():23. PubMed ID: 21269482
[TBL] [Abstract][Full Text] [Related]
20. Lupin protein influences the expression of hepatic genes involved in fatty acid synthesis and triacylglycerol hydrolysis of adult rats.
Bettzieche A; Brandsch C; Weisse K; Hirche F; Eder K; Stangl GI
Br J Nutr; 2008 May; 99(5):952-62. PubMed ID: 18096091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
